Assignee
ACTELION PHARMACEUTICALS LTD
CH·113 granted patents·52 pending applications·672 citations·filing 2000–2024
Top patents by PatentIndex Score
165 records- 0195US7875726B2Thiazolidin-4-one derivativesACTELION PHARMACEUTICALS LTD·Filed 2008·Granted Jan 25, 2011·24 cites·7 claims
- 0294US10220023B2Dosing regimen for a selective S1P1 receptor agonistACTELION PHARMACEUTICALS LTD·Filed 2015·Granted Mar 5, 2019·19 cites·12 claims
- 0394US7763638B2Substituted 1,2,3,4-tetrahydroisoquinoline derivativesACTELION PHARMACEUTICALS LTD·Filed 2005·Granted Jul 27, 2010·24 cites·6 claims
- 0494US7626037B2Thiazolidin-4-one derivativesACTELION PHARMACEUTICALS LTD·Filed 2008·Granted Dec 1, 2009·24 cites·24 claims
- 0594US7285549B2Sulfamides and their use as endothelin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2006·Granted Oct 23, 2007·27 cites·5 claims
- 0693US9173881B2Therapeutic compositions containing macitentanACTELION PHARMACEUTICALS LTD·Filed 2014·Granted Nov 3, 2015·8 cites·19 claims
- 0793USRE45174EThiazolidin-4-one derivativesACTELION PHARMACEUTICALS LTD·Filed 2013·Granted Sep 30, 2014·14 cites·8 claims
- 0892US9000018B2Thiazolidin-4-one-derivativesACTELION PHARMACEUTICALS LTD·Filed 2013·Granted Apr 7, 2015·13 cites·21 claims
- 0992US7994336B2Azetidine compounds as orexin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2007·Granted Aug 9, 2011·23 cites·15 claims
- 1092US7435828B2Thiazolidin-4-one derivativesACTELION PHARMACEUTICALS LTD·Filed 2004·Granted Oct 14, 2008·33 cites·27 claims
- 1191US11672783B2Pharmaceutical combination comprising a selective S1P1 receptor agonistACTELION PHARMACEUTICALS LTD·Filed 2021·Granted Jun 13, 2023·2 cites·15 claims
- 1291US11234980B2Pharmaceutical composition for the treatment of pulmonary arterial hypertensionACTELION PHARMACEUTICALS LTD·Filed 2021·Granted Feb 1, 2022·9 cites·30 claims
- 1391US8367685B2Stable pharmaceutical compositions comprising a pyrimidine-sulfamideACTELION PHARMACEUTICALS LTD·Filed 2009·Granted Feb 5, 2013·19 cites·16 claims
- 1491US7094781B2Sulfamides and their use as endothelin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2001·Granted Aug 22, 2006·38 cites·11 claims
- 1590US9597331B2Therapeutic compositions containing macitentanACTELION PHARMACEUTICALS LTD·Filed 2015·Granted Mar 21, 2017·3 cites·13 claims
- 1690US8003800B2Thiophene derivatives as S1P1/EDG1 receptor agonistsACTELION PHARMACEUTICALS LTD·Filed 2007·Granted Aug 23, 2011·18 cites·29 claims
- 1790US7750040B2Thiophene derivativesACTELION PHARMACEUTICALS LTD·Filed 2005·Granted Jul 6, 2010·17 cites·16 claims
- 1890US7723378B2Hydrogenated benzo (C) thiophene derivatives as immunomodulatorsACTELION PHARMACEUTICALS LTD·Filed 2006·Granted May 25, 2010·16 cites·20 claims
- 1989US11464777B2Pharmaceutical composition for the treatment of pulmonary arterial hypertensionACTELION PHARMACEUTICALS LTD·Filed 2021·Granted Oct 11, 2022·3 cites·23 claims
- 2089US10946015B2Stable pharmaceutical compositions comprising a pyrimidine-sulfamideACTELION PHARMACEUTICALS LTD·Filed 2018·Granted Mar 16, 2021·3 cites·42 claims
- 2189US7605269B2Thiophene derivatives as Sphingosine-1-phosphate-1 receptor agonistsACTELION PHARMACEUTICALS LTD·Filed 2006·Granted Oct 20, 2009·15 cites·17 claims
- 2288US10245253B2Pharmaceutical combination comprising a selective S1P1 receptor agonistACTELION PHARMACEUTICALS LTD·Filed 2015·Granted Apr 2, 2019·6 cites·12 claims
- 2388US8044076B2Phenyl derivatives and their use as immunomodulatorsACTELION PHARMACEUTICALS LTD·Filed 2007·Granted Oct 25, 2011·13 cites·19 claims
- 2488US7435815B2Sulfonylamino-acetic acid derivativesACTELION PHARMACEUTICALS LTD·Filed 2007·Granted Oct 14, 2008·10 cites·14 claims
- 2587US11026927B2Pharmaceutical combination comprising a selective S1P1 receptor agonistACTELION PHARMACEUTICALS LTD·Filed 2019·Granted Jun 8, 2021·4 cites·13 claims
- 2687US10653846B2Dosing apparatus for dispensing a fluid under aseptic conditionsACTELION PHARMACEUTICALS LTD·Filed 2016·Granted May 19, 2020·11 cites·12 claims
- 2787US9265762B2Stable pharmaceutical compositions comprising a pyrimidine-sulfamideACTELION PHARMACEUTICALS LTD·Filed 2013·Granted Feb 23, 2016·9 cites·16 claims
- 2886US8349828B2Azatricyclic antibiotic compoundsACTELION PHARMACEUTICALS LTD·Filed 2009·Granted Jan 8, 2013·5 cites·22 claims
- 2986US7834028B2Pyrazolo-tetrahydro pyridine derivatives as orexin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2007·Granted Nov 16, 2010·9 cites·19 claims
- 3085US7981924B2Thiophene derivativesACTELION PHARMACEUTICALS LTD·Filed 2006·Granted Jul 19, 2011·8 cites·34 claims
- 3185US2024131009A1Pharmaceutical combination comprising a selective s1p1 receptor agonistACTELION PHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 3284US9340518B2Process for the preparation of (2Z,5Z)-5-(3-chloro-4-((R)-2,3-dihydroxypropdxy)benzylidene)-2-(propylimino)-3-(o-tolyl)thiazolidin-4-one and intermediate used in said processACTELION PHARMACEUTICALS LTD·Filed 2013·Granted May 17, 2016·17 cites·18 claims
- 3384US8048881B2Pyrimidine derivatives and their use as P2Y12 receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2006·Granted Nov 1, 2011·9 cites·16 claims
- 3484US8003654B2N-glycinsulfonamide derivatives and uses as orexin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2007·Granted Aug 23, 2011·7 cites·12 claims
- 3584US7951794B2Thiophene derivativesACTELION PHARMACEUTICALS LTD·Filed 2006·Granted May 31, 2011·9 cites·16 claims
- 3684US7846964B2Thiophene derivatives as spingosine-1-phosphate-1 receptor agonistsACTELION PHARMACEUTICALS LTD·Filed 2006·Granted Dec 7, 2010·11 cites·22 claims
- 3783US9211279B2Proline sulfonamide derivatives as orexin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2015·Granted Dec 15, 2015·3 cites·30 claims
- 3883US7714132B2Tetrahydropyridoindole derivativesACTELION PHARMACEUTICALS LTD·Filed 2005·Granted May 11, 2010·7 cites·25 claims
- 3982US10117870B2Stable pharmaceutical compositions comprising a pyrimidine-sulfamideACTELION PHARMACEUTICALS LTD·Filed 2016·Granted Nov 6, 2018·3 cites·20 claims
- 4082US9493446B2Orexin receptor antagonists which are [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivativesACTELION PHARMACEUTICALS LTD·Filed 2013·Granted Nov 15, 2016·6 cites·21 claims
- 4182US6703392B21,2,3,4-tetrahydroisoquinoline derivativesACTELION PHARMACEUTICALS LTD·Filed 2001·Granted Mar 9, 2004·20 cites·22 claims
- 4281US8664278B2Stabilized compositions of volatile alkylating agents and methods of using thereofACTELION PHARMACEUTICALS LTD·Filed 2013·Granted Mar 4, 2014·3 cites·23 claims
- 4381US8044055B22-phenyl-6-aminocarbonyl-pyrimidine derivatives and their use as P2Y12 receptorACTELION PHARMACEUTICALS LTD·Filed 2007·Granted Oct 25, 2011·5 cites·12 claims
- 4481US7868012B2Sulfamides as endothelin receptor antagonists for the treatment of cardiovascular diseasesACTELION PHARMACEUTICALS LTD·Filed 2005·Granted Jan 11, 2011·4 cites·13 claims
- 4580US10251867B2Dosing regimen for a selective S1P1 receptor agonistACTELION PHARMACEUTICALS LTD·Filed 2015·Granted Apr 9, 2019·2 cites·7 claims
- 4680US9617250B2Pyridin-4-yl derivativesACTELION PHARMACEUTICALS LTD·Filed 2014·Granted Apr 11, 2017·4 cites·11 claims
- 4780US7192950B2Benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2001·Granted Mar 20, 2007·15 cites·5 claims
- 4879US8039644B2Hydrogenated benzo (C) thiophene derivatives as immunomodulatorsACTELION PHARMACEUTICALS LTD·Filed 2010·Granted Oct 18, 2011·4 cites·20 claims
- 4979US7279578B2Sulfonylamino-acetic acid derivativesACTELION PHARMACEUTICALS LTD·Filed 2003·Granted Oct 9, 2007·11 cites·14 claims
- 5078US7959945B2Dispersible bosentan tabletACTELION PHARMACEUTICALS LTD·Filed 2006·Granted Jun 14, 2011·4 cites·3 claims
Showing the top 50 of 165 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →